Business ❯Finance ❯Investments ❯Pharmaceuticals

Eli Lilly

Eli Lilly Shares Plunge After Disappointing Q3 Earnings and Sales

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs